Etidronate disodium is a bisphosphonate pharmaceutical agent used primarily to treat Paget's disease of bone and associated hypercalcemia by inhibiting osteoclastic activity. As the disodium salt form… Read more
Etidronate disodium is a bisphosphonate pharmaceutical agent used primarily to treat Paget's disease of bone and associated hypercalcemia by inhibiting osteoclastic activity. As the disodium salt form of etidronic acid, this compound helps reduce bone pain and prevent skeletal deformities in patients with metabolic bone disorders. Our selection of etidronate disodium reference standards includes the active pharmaceutical ingredient alongside critical related substances, such as pharmacopeial and non-pharmacopeial impurities and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories performing rigorous analytical testing, impurity profiling, and method validation to ensure the quality and consistency of drug formulations. By utilizing these high-quality standards, researchers can effectively monitor degradation products, confirm chemical identity, and maintain strict quality control standards throughout the development and manufacturing lifecycle of bisphosphonate therapeutics.